424 related articles for article (PubMed ID: 12717237)
1. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.
Eason JD; Nair S; Cohen AJ; Blazek JL; Loss GE
Transplantation; 2003 Apr; 75(8):1396-9. PubMed ID: 12717237
[TBL] [Abstract][Full Text] [Related]
2. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.
Eason JD; Loss GE; Blazek J; Nair S; Mason AL
Liver Transpl; 2001 Aug; 7(8):693-7. PubMed ID: 11510013
[TBL] [Abstract][Full Text] [Related]
3. Steroid-free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients.
Yoo MC; Vanatta JM; Modanlou KA; Campos L; Nezakatgoo N; Nair S; Eason JD
Transplantation; 2015 Jun; 99(6):1231-5. PubMed ID: 25539464
[TBL] [Abstract][Full Text] [Related]
4. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.
Tector AJ; Fridell JA; Mangus RS; Shah A; Milgrom M; Kwo P; Chalasani N; Yoo H; Rouch D; Liangpunsakul S; Herring S; Lumeng L
Liver Transpl; 2004 Mar; 10(3):404-7. PubMed ID: 15004768
[TBL] [Abstract][Full Text] [Related]
5. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP
Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827
[TBL] [Abstract][Full Text] [Related]
6. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
Pennington CA; Tischer SM; Lee E; Lee S; Sindelar J; Park JM
Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282
[TBL] [Abstract][Full Text] [Related]
8. A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.
Stevens RB; Foster KW; Miles CD; Lane JT; Kalil AC; Florescu DF; Sandoz JP; Rigley TH; Nielsen KJ; Skorupa JY; Kellogg AM; Malik T; Wrenshall LE
Transplantation; 2015 Jan; 99(1):197-209. PubMed ID: 25083614
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
Mangus RS; Fridell JA; Vianna RM; Kwo PY; Chen J; Tector AJ
Liver Transpl; 2012 Jul; 18(7):786-95. PubMed ID: 22237953
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
[TBL] [Abstract][Full Text] [Related]
11. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.
Saull HE; Enderby CY; Gonwa TA; Wadei HM
Clin Transplant; 2015 Jul; 29(7):573-80. PubMed ID: 25711849
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C.
Kamar N; Ribes D; Sandres-Saune K; Suc B; Barange K; Cointault O; Lavayssiere L; Durand D; Izopet J; Rostaing L
Transplant Proc; 2004 Nov; 36(9):2757-61. PubMed ID: 15621141
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of rATg/Daclizumab vs. rATg/Alemtuzumab as dual induction therapy in renal transplantation: Results at 8years of follow-up.
Ciancio G; Gaynor JJ; Guerra G; Sageshima J; Roth D; Chen L; Kupin W; Mattiazzi A; Tueros L; Flores S; Hanson L; Ruiz P; Vianna R; Burke GW
Transpl Immunol; 2017 Feb; 40():42-50. PubMed ID: 27888093
[TBL] [Abstract][Full Text] [Related]
14. Induction immunosuppression with rabbit antithymocyte globulin in pediatric liver transplantation.
Shah A; Agarwal A; Mangus R; Lim J; Fridell J; Vianna R; Tector AJ
Liver Transpl; 2006 Aug; 12(8):1210-4. PubMed ID: 16868953
[TBL] [Abstract][Full Text] [Related]
15. High dose rabbit antithymocyte globulin induction in living related liver transplantation.
Masetti M; Montalti R; Arpinati M; Di Benedetto F; Miller CM; Zagnoli A; De Ruvo N; Guerrini GP; Romano A; Rondelli D; Chirumbolo G; Rompianesi G; Pinna AD; Gerunda GE
Hepatogastroenterology; 2007; 54(75):884-8. PubMed ID: 17591084
[TBL] [Abstract][Full Text] [Related]
16. Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation.
Becker T; Foltys D; Bilbao I; D'Amico D; Colledan M; Bernardos A; Beckebaum S; Isoniemi H; Pirenne J; Jaray J;
Transplantation; 2008 Dec; 86(12):1689-94. PubMed ID: 19104406
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.
Eckhoff DE; McGuire BM; Frenette LR; Contreras JL; Hudson SL; Bynon JS
Transplantation; 1998 Jan; 65(2):180-7. PubMed ID: 9458011
[TBL] [Abstract][Full Text] [Related]
18. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology.
Stevens RB; Foster KW; Miles CD; Kalil AC; Florescu DF; Sandoz JP; Rigley TH; Malik T; Wrenshall LE
PLoS One; 2015; 10(10):e0139247. PubMed ID: 26465152
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.
Pilch NA; Taber DJ; Moussa O; Thomas B; Denmark S; Meadows HB; McGillicuddy JW; Srinivas TR; Baliga PK; Chavin KD
Ann Surg; 2014 May; 259(5):888-93. PubMed ID: 24513787
[TBL] [Abstract][Full Text] [Related]
20. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
Humar A; Crotteau S; Gruessner A; Kandaswamy R; Gruessner R; Payne W; Lake J
Clin Transplant; 2007; 21(4):526-31. PubMed ID: 17645714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
